The Rajiv Gandhi Cancer Institute in Delhi opened in 1996 as a charitable hospital and is North India's largest private not-for-profit cancer centre; it was among the first Indian centres to offer robotic cancer surgery, in-house next-generation sequencing and a large bone marrow transplant unit.
The Rajiv Gandhi Cancer Institute and Research Centre opened in Rohini, Delhi, in 1996 as a charitable cancer hospital and has become one of the largest dedicated cancer centres in India, with a second campus at Niti Bagh. It was among the first Indian centres to offer robotic cancer surgery, a large bone marrow transplant unit, in-house next-generation sequencing and molecular diagnostics, and modern radiotherapy including tomotherapy and stereotactic techniques. RGCI runs a DNB training programme, a tumour registry and a research wing, and participates in Indian and international multicentre trials in breast, head and neck, lung and haematological cancers.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Rajiv Gandhi Cancer Institute and Research Centre, including child institutions. 95 works · 241 citations · 76% open access · 12% clinical trials · 0% reviews.
Shares SBRT / SABR (stereotactic radiotherapy), Comprehensive genomic profiling, Cervical cancer, Head and neck squamous cell carcinoma.
Shares Robotic & minimally invasive surgery, Comprehensive genomic profiling, Head and neck squamous cell carcinoma, Diffuse large B-cell lymphoma.
Shares Robotic & minimally invasive surgery, SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer.
Shares SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, Diffuse large B-cell lymphoma, HR-positive / HER2-negative breast cancer.
Shares SBRT / SABR (stereotactic radiotherapy), Cervical cancer, Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam).
Shares Robotic & minimally invasive surgery, Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.
Shares SBRT / SABR (stereotactic radiotherapy), Cervical cancer, Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam).
Shares SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam), Non-small-cell lung cancer.